In this study, we describe a case involving a neonate diagnosed with MDS, characterized by two compound heterozygous mutations in the TK2 gene: a large deletion spanning exons 5–10, and a missense mutation, c.311G > A (p.Arg104His). This evidence concerns the gene TK2 and myelodysplastic syndrome.